These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 33979229)

  • 1. Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled clinical trial.
    Serena TE; Bullock NM; Cole W; Lantis J; Li L; Moore S; Patel K; Sabo M; Wahab N; Price P
    J Wound Care; 2021 May; 30(Sup5):S7-S14. PubMed ID: 33979229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of autologous whole blood clot in diabetic foot ulcers: a randomised controlled trial.
    Snyder R; Nouvong A; Ulloa J; Wahab N; Treadwell T; Bruwer F; Naude L; McGuire J; Reyzelman AM; Graham T; ; Lessing R; Lullove E; Ozker E; Pham HT; Pasternac M; Cohen S
    J Wound Care; 2024 Sep; 33(9):688-700. PubMed ID: 39287414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
    Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter clinical trial evaluating the durability of diabetic foot ulcer healing in ulcers treated with topical oxygen and standard of care versus standard of care alone 1 year post healing.
    Al-Jalodi O; Kupcella M; Breisinger K; Serena TE
    Int Wound J; 2022 Nov; 19(7):1838-1842. PubMed ID: 35437881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multinational, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy of Cyclical Topical Wound Oxygen (TWO2) Therapy in the Treatment of Chronic Diabetic Foot Ulcers: The TWO2 Study.
    Frykberg RG; Franks PJ; Edmonds M; Brantley JN; Téot L; Wild T; Garoufalis MG; Lee AM; Thompson JA; Reach G; Dove CR; Lachgar K; Grotemeyer D; Renton SC;
    Diabetes Care; 2020 Mar; 43(3):616-624. PubMed ID: 31619393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of autologous platelet-rich plasma gel in patients with hard-to-heal diabetic foot ulcers: a multicentre study in Japan.
    Ohura N; Kimura C; Ando H; Yuzuriha S; Furukawa M; Higashita R; Ayabe S; Tsuji Y; Fujii M; Terabe Y; Sakisaka M; Iwashina Y; Nakanishi A; Sasaki S; Hasegawa T; Kawauchi T; Hisamichi K
    J Wound Care; 2024 Jul; 33(7):484-494. PubMed ID: 38967341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hard-to-heal leg ulcers with an acid-oxidising solution versus standard of care: the MACAN study.
    Strohal R; Mittlböck M; Müller W; Hämmerle G
    J Wound Care; 2021 Sep; 30(9):694-704. PubMed ID: 34554831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial.
    Cazzell SM; Caporusso J; Vayser D; Davis RD; Alvarez OM; Sabolinski ML
    J Wound Care; 2024 Jul; 33(Sup7):S4-S14. PubMed ID: 38973638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
    O'Meara S; Cullum N; Majid M; Sheldon T
    Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Observational Clinical Trial Examining the Effect of Topical Oxygen Therapy (Natrox
    Tang TY; Mak MYQ; Yap CJQ; Boey JEC; Chan SL; Soon SXY; Ishak IAB; Lee RWL; Soh XJ; Goh WX
    Int J Low Extrem Wounds; 2024 Jun; 23(2):326-337. PubMed ID: 34747267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR; Reyzelman A; Kawalec J; French M
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous diffusion of oxygen improves diabetic foot ulcer healing when compared with a placebo control: a randomised, double-blind, multicentre study.
    Niederauer MQ; Michalek JE; Liu Q; Papas KK; Lavery LA; Armstrong DG
    J Wound Care; 2018 Sep; 27(Sup9):S30-S45. PubMed ID: 30207844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical Trial.
    Rastogi A; Kulkarni SA; Agarwal S; Akhtar M; Arsule S; Bhamre S; Bhosle D; Desai S; Deshmukh M; Giriraja KV; Jagannath J; Kashiva RY; Kesavan R; Khandelwal D; Kolte S; Kongara S; Darivemula AK; Madhusudan C; Pyare Saheb Qureshi MAH; Ramu M; Rathod G; Yalamanchi SR; Shakya S; Shetty P; Singh S; Deshpande SK; Viswanathan V; Unnikrishnan AG
    JAMA Netw Open; 2023 May; 6(5):e2311509. PubMed ID: 37184839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical oxygen treatment relieves pain from hard-to-heal leg ulcers and improves healing: a case report.
    Palin L; Nordgren M; Lingemark A; Jebril W; Wikstrom JD
    J Wound Care; 2021 Mar; 30(3):210-212. PubMed ID: 33729843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of combined hyperbaric oxygen therapy and topical haemoglobin spray in treating hard-to-heal sloughy wounds.
    Demir L
    J Wound Care; 2024 Oct; 33(10):796-802. PubMed ID: 39388208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial.
    Game F; Jeffcoate W; Tarnow L; Jacobsen JL; Whitham DJ; Harrison EF; Ellender SJ; Fitzsimmons D; Löndahl M;
    Lancet Diabetes Endocrinol; 2018 Nov; 6(11):870-878. PubMed ID: 30243803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LeucoPatch® system in the management of hard-to-heal diabetic foot ulcers: study protocol for a randomised controlled trial.
    Game F; Jeffcoate W; Tarnow L; Day F; Fitzsimmons D; Jacobsen J
    Trials; 2017 Oct; 18(1):469. PubMed ID: 29017535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
    Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
    J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.